TJX.US Weekly Report · 2026-W37
This week TJX declined 4.59%, hitting a 52-week low. Yet amid the selloff, institutions pushed aggressively higher: large-cap inflows reached $646M (net), Q2 EPS grew 23.64% YoY to $1.36, but weak Q3 guidance and Marmaxx underperformance dominated sentiment. Analysts maintain 13 buy vs. 4 hold ratings with a $169.8 price target—implying 34.74% upside. This contradiction reveals a market split between near-term caution and medium-term conviction that the stock is oversold.
Price Action
Closing at $126.02, down 4.59% from last Friday’s $132.08. Intra-week range of 5.40% ($132.00 high / $124.87 low), with price gapping lower at open Monday then probing systematically downward through the week. Daily average volume of 7.918M shares, steady with recent levels—neither flush nor squeeze. Price action shows a “high-open, low-close” pattern: Monday gap down of -2.30% (131.26 → 128.09), followed by shallow recovery attempts that failed to reclaim Monday’s open, then progressively lower lows each day. Final two sessions saw volume contract to 6.2M / 5.9M shares, signaling absent buying interest.
Valuation and Position
PE of 22.85x sits at the 5.5th percentile over five years—cheaper than 94.5% of its history, classifying as extreme undervaluation. Yet paradoxically, relative to peers it remains inflated: industry median PE is just 9.37x, making TJX trade at a 144% premium to sector. This disconnect hints at the market pricing in medium-term growth potential, but weakening guidance is eroding that premium. PB of 13.01x is mid-range; market cap $138.6B.
Earnings Delivery
Q2 FY27 (ended August 2026): EPS $1.36, +23.64% YoY, beating consensus (~$1.31). Net sales $15.2B, +5.41% YoY. Net income $1.52B, +22.28% YoY. Net margin 10.01%, up ~137 bps year-over-year—a material improvement.
The problem lies in Q3 guidance: management signaled comp-store sales growth will decelerate below Q2’s 4%, with Marmaxx (flagship division) under particular pressure. Ross Stores’ Q2 comp of +10% exposes TJX’s 4% as pedestrian. Latest EPS consensus of $5.409 (median $5.39) trails current TTM of $5.52, reflecting investor caution on next-year growth rates.
Capital Flows
Large-cap inflows net $646M, mid-cap net $680M, retail net $143M—all three tiers flowing in the same direction, a rare multi-layer buy signal. Yet this collides with a 5% weekly decline: textbook “institutional accumulation on panic selling.” Institutions are exploiting fear to build positions, retail is following, but aggregate demand remains insufficient to arrest the momentum decline.
Institutional View
Rating distribution: 13 buy, 4 hold, 1 no opinion, 0 sell. Overwhelmingly bullish, ranked #1 of 37 in apparel retail. Latest target $169.8 (issued Sept 7) implies 34.74% upside to Friday close. This reflects analyst conviction that current valuation has overshot to the downside and mean reversion awaits. However, these ratings predate the full impact of soft guidance—they lag price signals.
This Week’s News
Main Theme: Q2 beat offset by Q3 guidance miss; institutions buy the dip as guidance concerns peak.
- TJX FY27 Q2 EPS climbs 23.64% to $1.36; net sales rise 5% to $15.2 billion
- TJX hits 52-week low as Q2 sales growth lags Ross Stores
- Sequoia Financial Advisors LLC Increases Stock Position in The TJX Companies, Inc. $TJX
- Weekly Recap | TJX -2.25%, hitting fresh 52-week lows
- Fundsmith LLP Invests $344.30 Million in The TJX Companies, Inc. $TJX
- TJX Companies declares R$ 1.66 dividend per unit, payable Sept. 10
- VIRGINIA RETIREMENT SYSTEMS ET Al Invests $49.68 Million in The TJX Companies, Inc. $TJX
- Bank OZK Acquires 10,103 Shares of The TJX Companies, Inc. $TJX
- In off price, Ross is the new boss
- US retail’s stark divergence highlights macro consumer pressures and structural resets
Summary
Signal Contradiction: This week TJX embodied a “mixed signals” outcome. Fundamentally, Q2 EPS +23.64% and net margin at new high of 10.01% point to strengthening profitability; valuation at PE 22.85 (5.5 percentile) does look cheap. These offsets were negated by two headwinds—Q3 guidance flagged deceleration in comps, and Marmaxx growth slowdown suggests heritage brand has hit its growth ceiling.
Capital vs. Rating Divergence: Multi-tier institutional net inflows (646M large + 680M mid + 143M retail) combined with 13-buy-vs-4-hold consensus sit awkwardly against a 4.59% weekly decline. Institutions appear to be pricing in near-term pain and positioning for medium-term recovery. The paradox of a PE trading at 5.5 percentile of five-year history yet 144% above industry median captures this perfectly: the market believes current levels are overdiscounted—but only if Q3 doesn’t break again.
Risk: If Q3 earnings disappoint further or Marmaxx cannot stabilize, institutional accumulation becomes value destruction; the $169.8 target loses credibility. This is a node of simultaneous high risk and high opportunity.